Allergy Therapeutics to sniff out more M&A deals - Manuel Llobert, CEO, Allergy Therapeutics 00:00:00

Share On Facebook Share On Twitter

Manuel Llobert, chief executive of Allergy Therapeutics says firm the is far better placed to make acquisitions given the recent increase in its market value.

Recent Videos